Cargando…
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling
Transferrin receptor 2 (Tfr2) is mainly expressed in the liver and controls iron homeostasis. Here, we identify Tfr2 as a regulator of bone homeostasis that inhibits bone formation. Mice lacking Tfr2 display increased bone mass and mineralization independent of iron homeostasis and hepatic Tfr2. Bon...
Autores principales: | Rauner, Martina, Baschant, Ulrike, Roetto, Antonella, Pellegrino, Rosa Maria, Rother, Sandra, Salbach-Hirsch, Juliane, Weidner, Heike, Hintze, Vera, Campbell, Graeme, Petzold, Andreas, Lemaitre, Regis, Henry, Ian, Bellido, Teresita, Theurl, Igor, Altamura, Sandro, Colucci, Silvia, Muckenthaler, Martina U., Schett, Georg, Komla Ebri, Davide, Bassett, J. H. Duncan, Williams, Graham R., Platzbecker, Uwe, Hofbauer, Lorenz C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420074/ https://www.ncbi.nlm.nih.gov/pubmed/30886999 http://dx.doi.org/10.1038/s42255-018-0005-8 |
Ejemplares similares
-
Transferrin receptor 2 deficiency promotes macrophage polarization and inflammatory arthritis
por: Ledesma-Colunga, Maria G., et al.
Publicado: (2023) -
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice
por: Weidner, Heike, et al.
Publicado: (2022) -
Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss
por: Lehmann, Juliane, et al.
Publicado: (2021) -
Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway
por: Balaian, Ekaterina, et al.
Publicado: (2018) -
Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus
por: Hildebrandt, Nick, et al.
Publicado: (2021)